E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma

por Maksimos, Mina, Muz, Barbara, Magnani, John L., Azab, Abdel Kareem
Publicado 2023

Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis

por Muz, Barbara, Khan, Moddasar N, Kiriakidis, Serafim, Paleolog, Ewa M
Publicado 2009

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

por Muz, Barbara, de la Puente, Pilar, Azab, Feda, Azab, Abdel Kareem
Publicado 2015

Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA

por Larsen, Helene, Muz, Barbara, Khong, Tak L, Feldmann, Marc, Paleolog, Ewa M
Publicado 2012

Molecularly Targeted Therapies in Multiple Myeloma

por de la Puente, Pilar, Muz, Barbara, Azab, Feda, Luderer, Micah, Azab, Abdel Kareem
Publicado 2014

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma

por Muz, Barbara, Azab, Feda, de la Puente, Pilar, Landesman, Yosef, Azab, Abdel Kareem
Publicado 2017

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies

por Sun, Jennifer, Chen, Yixuan, Lubben, Berit, Adebayo, Ola, Muz, Barbara, Azab, Abdel Kareem
Publicado 2021

Spotlight on ixazomib: potential in the treatment of multiple myeloma

por Muz, Barbara, Ghazarian, Rachel Nicole, Ou, Monica, Luderer, Micah John, Kusdono, Hubert Daniel, Azab, Abdel Kareem
Publicado 2016

Targeting E-selectin to Tackle Cancer Using Uproleselan

por Muz, Barbara, Abdelghafer, Anas, Markovic, Matea, Yavner, Jessica, Melam, Anupama, Salama, Noha Nabil, Azab, Abdel Kareem
Publicado 2021

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

por Muz, Barbara, Azab, Feda, de la Puente, Pilar, Rollins, Scott, Alvarez, Richard, Kawar, Ziad, Azab, Abdel Kareem
Publicado 2015

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

por Muz, Barbara, Azab, Feda, Fiala, Mark, King, Justin, Kohnen, Daniel, Fogler, William E., Smith, Ted, Magnani, John L., Vij, Ravi, Azab, Abdel Kareem
Publicado 2019

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

por Alhallak, Kinan, Sun, Jennifer, Muz, Barbara, Jeske, Amanda, O’Neal, Julie, Ritchey, Julie K., Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Publicado 2022

The myeloid binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting

por Lu, Zhi Hong, Kaliberov, Sergey, Zhang, Jingzhu, Muz, Barbara, Azab, Abdel Kareem, Sohn, Rebecca E., Kaliberova, Lyudmila, Du, Yingqiu, Curiel, David T., Arbeit, Jeffrey M.
Publicado 2014

Tumor-associated macrophages in multiple myeloma: advances in biology and therapy

por Sun, Jennifer, Park, Chaelee, Guenthner, Nicole, Gurley, Shannon, Zhang, Luna, Lubben, Berit, Adebayo, Ola, Bash, Hannah, Chen, Yixuan, Maksimos, Mina, Muz, Barbara, Azab, Abdel Kareem
Publicado 2022

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction

por Massalska, Magdalena, Ciechomska, Marzena, Kuca-Warnawin, Ewa, Burakowski, Tomasz, Kornatka, Anna, Radzikowska, Anna, Pawlak, Dariusz, Muz, Barbara, Loniewska-Lwowska, Adrianna, Palucha, Andrzej, Maldyk, Pawel, Maslinski, Wlodzimierz
Publicado 2022

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

por Alhallak, Kinan, Sun, Jennifer, Muz, Barbara, Jeske, Amanda, Yavner, Jessica, Bash, Hannah, Park, Chaelee, Lubben, Berit, Adebayo, Ola, Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

por Alhallak, Kinan, Jeske, Amanda, de la Puente, Pilar, Sun, Jennifer, Fiala, Mark, Azab, Feda, Muz, Barbara, Sahin, Ilyas, Vij, Ravi, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

por Alhallak, Kinan, Sun, Jennifer, Wasden, Katherine, Guenthner, Nicole, O’Neal, Julie, Muz, Barbara, King, Justin, Kohnen, Daniel, Vij, Ravi, Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma

por Sun, Jennifer, Muz, Barbara, Alhallak, Kinan, Markovic, Matea, Gurley, Shannon, Wang, Zhe, Guenthner, Nicole, Wasden, Katherine, Fiala, Mark, King, Justin, Kohnen, Daniel, Salama, Noha Nabil, Vij, Ravi, Azab, Abdel Kareem
Publicado 2020

An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma

por Darawshi, Odai, Muz, Barbara, Naamat, Shiri Gershon, Praveen, Bellam, Mahameed, Mohamed, Goldberg, Karin, Dipta, Priya, Shmuel, Miriam, Forno, Francesca, Boukeileh, Shatha, Pahima, Hadas, Hermann, Julia, Raab, Marc S., Poos, Alexandra M., Weinhold, Niels, Rosenbluh, Chaggai, Gatt, Moshe E., Palm, Wilhelm, Azab, Abdel Kareem, Tirosh, Boaz
Publicado 2022